Back to search

Article

Spatial Analysis Uncovers Immune Resistance Mechanisms in Non-Beneficial Hepatocellular Carcinoma Treated with Y90 Radioembolization-Nivolumab

2026-07-13

Abstract excerpt

<h4>Background & Aims</h4> Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality, with most patients presenting at advanced stages requiring systemic therapy. Despite promising outcomes with immune checkpoint inhibitors (ICI), responses remain variable due to an immunosuppressive tumor microenvironment. Y90 radioembolization offers potential immune priming, but only a subset of patients benef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5a93168-d008-5908-b751-a882f3638c67
DOI
10.64898/2026.07.10.26357712
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Spatial Analysis Uncovers Immune Resistance Mechanisms in Non-Beneficial Hepatocellular Carcinoma Treated with Y90 Radioembolization-NivolumabDOI 10.64898/2026.07.10.26357712
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrenceSemantic proximity
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbiditySemantic proximity
Multi-Omics Deciphering of the Characteristics, Functional Mechanisms, and Prognostic Value of Tumor-Associated Macrophage Subsets in Hepatocellular CarcinomaSemantic proximity
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseSemantic proximity
An integrated single-cell atlas of checkpoint inhibitor-induced liver injury links shared liver-tumour CD8+ T cell clones to cytotoxicity and macrophage crosstalksSemantic proximity
Differential T-cell and monocyte responses in hepatocellular carcinoma treated with regorafenib plus nivolumab: an integrated clinical and biomarker analysis of the phase 2 RENOBATE trialSemantic proximity
Multi-omics analysis reveals the role of tumor-infiltrating CD4+CCR7+ T cells in EGFR antibody resistance and prognosis of hepatocellular carcinomaSemantic proximity
Deep spatial-omics to aid personalization of precision medicine in metastatic recurrent Head & Neck CancersSemantic proximity
Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinomaSemantic proximity
Distinct Spatial Programs of Response versus Resistance in Non-Small Cell Lung Cancer after Neoadjuvant ChemoimmunotherapySemantic proximity
High ratio of resident to exhausted CD4+ T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinomaSemantic proximity
Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progressionSemantic proximity
Select a neighboring publication to make it the new centre.